NCT03827590

Clinical Trials to Assess the Efficacy and Safety of HLIM

Phase III Clinical Trials to Assess the Efficacy and Safety of HLIM for Symptomatic Relief of Cough and Sputum in Patients With Acute Upper Respiratory Tract Infection or Acute Bronchitis

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 487 (estimated)
• Sponsor: SamA Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 2 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the efficacy and safety of HLIM

Detailed description

A randomized, double-blind, active-controlled, multicenter phase 3 clinical trial.

Conditions

• Acute Upper Respiratory Tract Infection
• Acute Bronchitis

Interventions

Type	Name	Description
DRUG	Test	three times a day for five days
DRUG	Active Comparator Control 1	three times a day for five days
DRUG	Active Comparator Control 2	three times a day for five days
DRUG	Placebo	three times a day for five days

Timeline

• Start date: 2018-11-29
• Primary completion: 2019-05-30
• Completion: 2019-10-31
• First posted: 2019-02-01
• Last updated: 2019-02-08

Locations

1 site across 1 country: South Korea